Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

RegeneRx Biopharmaceuticals, Inc. RGRX OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
31/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

RegeneRx Biopharmaceuticals, Inc. (RGRX) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

RGRX Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to RegeneRx Biopharmaceuticals, Inc. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

FBIOP
FBIOP
Fortress Biotech, Inc.
$13.37
-2.33%
 MSSTF
MSSTF
Mindset Pharma Inc.
$0.54
-0.37%
 ACOGF
ACOGF
Alpha Cognition Inc.
$5.73
+0.00%
 SILO
SILO
Silo Pharma, Inc.
$0.40
-7.17%
 PKTX
PKTX
ProtoKinetix, Incorporated
$0.01
+47.66%
 AWKNF
AWKNF
Awakn Life Sciences Corp.
$0.07
+0.00%
 VGLS
VGLS
VG Life Sciences Inc.
$0.00
+0.00%
 ONPH
ONPH
Oncology Pharma Inc.
$0.07
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message